A detailed history of Bank Of America Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 786,896 shares of SWTX stock, worth $25.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
786,896
Previous 1,025,832 23.29%
Holding current value
$25.7 Million
Previous $50.5 Million 41.29%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$36.06 - $47.62 $8.62 Million - $11.4 Million
-238,936 Reduced 23.29%
786,896 $29.6 Million
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $24.5 Million - $35.2 Million
670,484 Added 188.68%
1,025,832 $50.5 Million
Q4 2023

Feb 14, 2024

SELL
$18.94 - $37.24 $28 Million - $55 Million
-1,477,753 Reduced 80.61%
355,348 $13 Million
Q2 2023

Aug 14, 2023

SELL
$23.15 - $32.71 $1.99 Million - $2.81 Million
-85,861 Reduced 4.47%
1,833,101 $48.1 Million
Q1 2023

May 12, 2023

BUY
$24.97 - $34.05 $3.09 Million - $4.21 Million
123,559 Added 6.88%
1,918,962 $49.4 Million
Q4 2022

Feb 10, 2023

BUY
$21.73 - $28.72 $1.86 Million - $2.46 Million
85,627 Added 5.01%
1,795,403 $46.7 Million
Q3 2022

Nov 14, 2022

BUY
$24.1 - $39.66 $1.53 Million - $2.52 Million
63,433 Added 3.85%
1,709,776 $48.8 Million
Q2 2022

Aug 12, 2022

BUY
$18.36 - $60.07 $346,196 - $1.13 Million
18,856 Added 1.16%
1,646,343 $40.5 Million
Q1 2022

May 16, 2022

BUY
$48.97 - $65.46 $5.54 Million - $7.4 Million
113,114 Added 7.47%
1,627,487 $91.9 Million
Q4 2021

Feb 08, 2022

BUY
$53.3 - $75.84 $20 Million - $28.4 Million
374,608 Added 32.87%
1,514,373 $93.9 Million
Q3 2021

Nov 15, 2021

BUY
$62.66 - $88.26 $23 Million - $32.4 Million
367,303 Added 47.55%
1,139,765 $72.3 Million
Q2 2021

Sep 13, 2021

BUY
$67.45 - $85.63 $52.1 Million - $66.1 Million
772,462 New
772,462 $63.7 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.04B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.